Pharmacyclics LLC v. Alvogen, Inc.
Plaintiff / Appellee: PHARMACYCLICS LLC and JANSSEN BIOTECH, INC.
Defendant / Appellant: ALVOGEN PINE BROOK, LLC, NATCO PHARMA LIMITED and ALVOGEN, INC.
Case Number: 21-2270
Filed: August 31, 2021
Court: U.S. Court of Appeals, Federal Circuit
Nature of Suit: Patent - (ANDA) (Fed. Qst.)

Opinions

We have the following opinions for this case:

Date Filed Description
November 15, 2022 PHARMACYCLICS LLC v. ALVOGEN, INC.

RSS RSS Track this Docket
Docket Report

This docket was last retrieved on December 22, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
December 22, 2022 Opinion or Order Filing 61 Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [892431] [MVH] [Entered: 12/22/2022 11:56 AM]
November 15, 2022 Opinion or Order Filing 60 JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click # here . Service as of this date by the Clerk of Court. [884094] [MVH] [Entered: 11/15/2022 10:32 AM]
November 15, 2022 Opinion or Order Filing 59 OPINION filed for the court by Chen, Circuit Judge; Bryson, Circuit Judge and Hughes, Circuit Judge. Nonprecedential Opinion. Service as of this date by the Clerk of Court. [884091] [MVH] [Entered: 11/15/2022 10:32 AM]
October 7, 2022 Opinion or Order Filing 58 Submitted after ORAL ARGUMENT to Panel: Chen, Circuit Judge; Bryson, Circuit Judge and Hughes, Circuit Judge. Arguing counsel: Siegmund Y. Gutman for Natco Pharma Limited and Alvogen, Inc. and Christopher Neil Sipes for Pharmacyclics LLC. Oral Argument Audio available # here . [876591] [MJL] [Entered: 10/07/2022 11:26 AM]
October 3, 2022 Opinion or Order Filing 57 MODIFIED ENTRY: RESPONSE of Janssen Biotech, Inc. and Pharmacyclics LLC to Doc No. [ # 56 ]. Service: 10/03/2022 by email. [875469]--[Edited 10/04/2022 by MJL to correct filing event] [Christopher Sipes] [Entered: 10/03/2022 04:35 PM]
September 30, 2022 Opinion or Order Filing 56 Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 09/30/2022 by email. [875208] [21-2270] [Siegmund Gutman] [Entered: 09/30/2022 08:33 PM]
September 6, 2022 Opinion or Order Filing 55 Form 33A. Certificate of Compliance with Revised Protocols for In-Person Arguments for Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 09/06/2022 by email. [870147] [21-2270] [Siegmund Gutman] [Entered: 09/06/2022 04:47 PM]
September 6, 2022 Opinion or Order Filing 54 Response to notice of oral argument from Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 09/06/2022 by email. [870144] [21-2270] [Siegmund Gutman] [Entered: 09/06/2022 04:41 PM]
September 2, 2022 Opinion or Order Filing 53 Response to notice of oral argument from Appellees Janssen Biotech, Inc. and Pharmacyclics LLC. Service: 09/02/2022 by email. [869832] [21-2270] [Christopher Sipes] [Entered: 09/02/2022 04:45 PM]
September 2, 2022 Opinion or Order Filing 52 Response to notice of oral argument from Appellees Janssen Biotech, Inc. and Pharmacyclics LLC. Service: 09/02/2022 by email. [869829] [21-2270] [Christopher Sipes] [Entered: 09/02/2022 04:41 PM]
August 22, 2022 Opinion or Order Filing 51 NOTICE OF ORAL ARGUMENT. Panel: 2210H. Case scheduled October 7, 2022. Response to Notice of Oral Argument due: 09/06/2022. Please review the attached Notice. The response to notice of oral argument form can be found # here . The Oral Argument Guide can be found # here . Service as of this date by the Clerk of Court. [867692] [MVH] [Entered: 08/22/2022 04:11 PM]
July 21, 2022 Opinion or Order Filing 50 Notice from Appellants Alvogen, Inc. and Natco Pharma Limited Notice of Withdrawal of Non-Principal Counsel Amir A. Naini. Service: 07/21/2022 by email. [862280] [21-2270] [Amir Naini] [Entered: 07/21/2022 01:42 PM]
June 16, 2022 Opinion or Order Filing 49 Notice from Appellees Janssen Biotech, Inc. and Pharmacyclics LLC regarding conflicts with oral argument. None. Service: 06/16/2022 by email. [856029] [21-2270] [Christopher Sipes] [Entered: 06/16/2022 03:50 PM]
May 11, 2022 Opinion or Order Filing 48 The following conflict dates submitted by Christopher Neil Sipes for Pharmacyclics LLC have been accepted by the court: 09/06/2022, 09/07/2022, 09/08/2022. [849239] [MJL] [Entered: 05/11/2022 02:58 PM]
May 11, 2022 Opinion or Order Filing 47 The following conflict dates submitted by Siegmund Y. Gutman for Natco Pharma Limited and Alvogen, Inc. have been accepted by the court: 08/01/2022, 08/02/2022, 08/03/2022, 08/04/2022, 08/05/2022, 10/04/2022, 10/05/2022, 10/06/2022. [849238] [MJL] [Entered: 05/11/2022 02:56 PM]
May 5, 2022 Opinion or Order Filing 46 Notice from Appellee Janssen Biotech, Inc. regarding conflicts with oral argument. Service: 05/05/2022 by email. [847961] [21-2270] [Christopher Sipes] [Entered: 05/05/2022 04:48 PM]
May 5, 2022 Opinion or Order Filing 45 Notice from Appellee Janssen Biotech, Inc. regarding conflicts with oral argument. Service: 05/05/2022 by email. [847927] [21-2270] [Christopher Sipes] [Entered: 05/05/2022 04:13 PM]
May 5, 2022 Opinion or Order Filing 44 Notice from Appellants Alvogen, Inc. and Natco Pharma Limited regarding conflicts with oral argument. Service: 05/05/2022 by email. [847801] [21-2270] [Siegmund Gutman] [Entered: 05/05/2022 12:42 PM]
May 4, 2022 Opinion or Order Filing 42 6 paper copies of Doc. No. [38], [ # 32 ], [ # 25 ] received from Appellants Alvogen, Inc., Natco Pharma Limited and Appellee Janssen Biotech, Inc.. [847592] [VDW] [Entered: 05/04/2022 04:03 PM]
May 2, 2022 Opinion or Order Filing 43 6 paper copies of Doc. No. [ # 28 ] received from Appellees Pharmacyclics LLC and Janssen Biotech, Inc. [847597]--[Edited 05/27/2022 by JCP to include Janssen] [VDW] [Entered: 05/04/2022 04:07 PM]
April 28, 2022 Opinion or Order Filing 41 Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found # here . The Oral Argument Guide can be found # here . [846089] [JCW] [Entered: 04/28/2022 03:42 PM]
April 28, 2022 Opinion or Order Filing 40 Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [846088] [JCW] [Entered: 04/28/2022 03:42 PM]
April 28, 2022 Opinion or Order Filing 39 ORDER filed granting motion to waive requirements of brief or appendix [ # 36 ] filed by Appellants. ECF Nos. 37 and 38 are accepted as the nonconfidential and confidential versions, respectively, of the joint appendix. Service as of this date by the Clerk of Court. [846085] [NL] [Entered: 04/28/2022 03:22 PM]
April 15, 2022 Opinion or Order Filing 38 MODIFIED ENTRY: CONFIDENTIAL APPENDIX FILED by Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 04/15/2022 by email. [843657]--[Edited 04/28/2022 by JCW - compliance review complete] [Siegmund Gutman] [Entered: 04/15/2022 06:31 PM]
April 15, 2022 Opinion or Order Filing 37 MODIFIED ENTRY: APPENDIX FILED by Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 04/15/2022 by email. [843656] --[Edited 04/28/2022 by JCW - compliance review complete] [Siegmund Gutman] [Entered: 04/15/2022 06:20 PM]
April 15, 2022 Opinion or Order Filing 36 MOTION of Appellants Alvogen, Inc. and Natco Pharma Limited to waive appendix requirement(s). Service: 04/15/2022 by email. [843646] [21-2270] [Siegmund Gutman] [Entered: 04/15/2022 05:29 PM]
April 15, 2022 Opinion or Order Filing 35 Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellees Janssen Biotech, Inc. and Pharmacyclics LLC. Service: 04/15/2022 by email. [843631] [21-2270] [Christopher Sipes] [Entered: 04/15/2022 04:44 PM]
April 15, 2022 Opinion or Order Filing 34 Amended Certificate of Interest for Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 04/15/2022 by email. [843401] [21-2270] [Siegmund Gutman] [Entered: 04/15/2022 10:02 AM]
April 15, 2022 Opinion or Order Filing 33 Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 04/15/2022 by email. [843394] [21-2270] [Siegmund Gutman] [Entered: 04/15/2022 09:59 AM]
April 8, 2022 Opinion or Order Filing 32 MODIFIED ENTRY: REPLY BRIEF FILED by Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 04/08/2022 by email. [842174] --[Edited 04/11/2022 by JCW - compliance review complete] [Siegmund Gutman] [Entered: 04/08/2022 05:13 PM]
March 11, 2022 Opinion or Order Filing 31 **TEXT ONLY** ORDER granting motion to extend time to file brief [ # 30 ] filed by Appellants Natco Pharma Limited and Alvogen, Inc. The reply brief is due 04/08/2022.. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [836476] [JCW] [Entered: 03/11/2022 04:55 PM]
March 11, 2022 Opinion or Order Filing 30 MOTION of Appellants Alvogen, Inc. and Natco Pharma Limited to extend time. Service: 03/11/2022 by email. [836423] [21-2270] [Siegmund Gutman] [Entered: 03/11/2022 03:39 PM]
March 11, 2022 Opinion or Order Filing 29 Notice from Appellee Pharmacyclics LLC Withdrawal of appearance of Laura Dolbow for Pharmacyclics LLC. Service: 03/11/2022 by email. [836295] [21-2270] [Laura Dolbow] [Entered: 03/11/2022 11:15 AM]
March 4, 2022 Opinion or Order Filing 28 MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellees Janssen Biotech, Inc. and Pharmacyclics LLC. Service: 03/04/2022 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [835056] --[Edited 03/07/2022 by JCW - compliance review complete] [Christopher Sipes] [Entered: 03/04/2022 07:30 PM]
December 30, 2021 Opinion or Order Filing 27 **TEXT ONLY** ORDER granting motion to extend time to file brief [ # 26 ] filed by Appellees Janssen Biotech, Inc. and Pharmacyclics LLC. The response brief is due 03/04/2022. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [821967] [EKD] [Entered: 12/30/2021 10:58 AM]
December 29, 2021 Opinion or Order Filing 26 MOTION of Appellees Janssen Biotech, Inc. and Pharmacyclics LLC to extend the time to 03/04/2022 to file brief. Service: 12/29/2021 by clerk, email. [821880] [21-2270] [Irena Royzman] [Entered: 12/29/2021 06:08 PM]
December 7, 2021 Opinion or Order Filing 25 MODIFIED ENTRY: CORRECTED OPENING BRIEF FILED by Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 12/07/2021 by email. [816951] --[Edited 12/08/2021 by JCW - compliance review complete] [Siegmund Gutman] [Entered: 12/07/2021 05:00 PM]
December 7, 2021 Opinion or Order Filing 24 NOTICE OF NON-COMPLIANCE: The submission of Appellants Alvogen, Inc. and Natco Pharma Limited, Opening Brief [ # 23 ], is not in compliance with the rules of this court (see attached). Compliant document due on 12/14/2021. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [816697] [JCW] [Entered: 12/07/2021 09:48 AM]
December 6, 2021 Opinion or Order Filing 23 OPENING BRIEF FILED by Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 12/06/2021 by email. [816611] [21-2270] This document is non-compliant. See Doc No.[ # 24 ] [Siegmund Gutman] [Entered: 12/06/2021 05:52 PM]
December 1, 2021 Opinion or Order Filing 22 ORDER filed denying [ # 19 ] motion to waive requirements of brief or appendix filed by Natco Pharma Limited and Alvogen, Inc. (Per Curiam). Service as of this date by the Clerk of Court. [815668] [LMS] [Entered: 12/01/2021 03:09 PM]
November 26, 2021 Opinion or Order Filing 21 RESPONSE of Appellees Pharmacyclics LLC and Janssen Biotech, Inc. to Doc No. [ # 19 ]. Service: 11/26/2021 by email. [814890] [21-2270] [Christopher Sipes] [Entered: 11/26/2021 10:38 AM]
November 24, 2021 Opinion or Order Filing 20 Amended Certificate of Interest for Appellee Janssen Biotech, Inc.. Service: 11/24/2021 by clerk, email. [814867] [21-2270] [Irena Royzman] [Entered: 11/24/2021 05:59 PM]
November 23, 2021 Opinion or Order Filing 19 MOTION of Appellants Alvogen, Inc. and Natco Pharma Limited to waive brief requirement(s). Service: 11/23/2021 by email. [814618] [21-2270] [Siegmund Gutman] [Entered: 11/23/2021 05:54 PM]
November 3, 2021 Opinion or Order Filing 18 Amended Entry of appearance for Irena Royzman; Hannah Lee; Christine Wilgoos; Daniel David Williams as counsel for Appellee Janssen Biotech, Inc.. Service: 11/03/2021 by clerk, email. [810043] [21-2270] [Irena Royzman] [Entered: 11/03/2021 03:34 PM]
October 18, 2021 Opinion or Order Filing 17 ORDER granting motion to substitute party [ # 15 ] filed by Appellant Alvogen Pine Brook, LLC. Appellant Alvogen Pine Brook, LLC in 21-2270 substituted by Appellant Alvogen, Inc. in 21-2270. The revised official caption and short caption are reflected in this order; granting motion to extend time to file brief [ # 16 ] filed by Appellants. The opening brief is due 12/06/2021. Service as of this date by the Clerk of Court. [806486] [LMS] [Entered: 10/18/2021 02:58 PM]
October 14, 2021 Filing 16 MOTION of Appellants Alvogen Pine Brook, LLC and Natco Pharma Limited to extend the time to 12/06/2021 to file brief. Service: 10/14/2021 by email. [805839] [21-2270] [Siegmund Gutman] [Entered: 10/14/2021 05:21 PM]
October 7, 2021 Filing 15 MOTION of Appellant Alvogen Pine Brook, LLC to substitute party. Service: 10/07/2021 by email. [804451] [21-2270] [Siegmund Gutman] [Entered: 10/07/2021 06:44 PM]
September 17, 2021 Filing 14 Corrected Entry of appearance for Irena Royzman; Hannah Lee; Christine Willgoos as counsel for Appellee Janssen Biotech, Inc.. Service: 09/17/2021 by clerk, email. [800309] [21-2270] [Irena Royzman] [Entered: 09/17/2021 01:45 PM]
September 17, 2021 Filing 13 Amended Entry of appearance for Siegmund Y. Gutman; John E. Roberts; Amir A. Naini; David M. Hanna as counsel for Appellants Alvogen Pine Brook, LLC and Natco Pharma Limited. Service: 09/17/2021 by email. [800289] [21-2270] [Siegmund Gutman] [Entered: 09/17/2021 12:59 PM]
September 15, 2021 Filing 12 NOTICE OF NON-COMPLIANCE: The submission of Appellee Janssen Biotech, Inc., Entry of Appearance [ # 5 ], is not in compliance with the rules of this court (see attached). Service as of this date by the Clerk of Court. [799382] [JCW] [Entered: 09/15/2021 08:39 AM]
September 15, 2021 Filing 11 NOTICE OF NON-COMPLIANCE: The submission of Appellants Alvogen Pine Brook, LLC and Natco Pharma Limited, Entry of Appearance [ # 10 ], is not in compliance with the rules of this court (see attached). Compliant document due on 09/22/2021. Service as of this date by the Clerk of Court. [799379] [JCW] [Entered: 09/15/2021 08:35 AM]
September 14, 2021 Filing 10 Docketing Statement for the Appellants Alvogen Pine Brook, LLC and Natco Pharma Limited. Service: 09/14/2021 by email. [799333] [21-2270] This document is non-compliant. See Doc No.[ # 11 ] [Siegmund Gutman] [Entered: 09/14/2021 07:34 PM]
September 14, 2021 Filing 9 Certificate of Interest for Appellants Alvogen Pine Brook, LLC and Natco Pharma Limited. Service: 09/14/2021 by email. [799332] [21-2270] [Siegmund Gutman] [Entered: 09/14/2021 07:33 PM]
September 14, 2021 Filing 8 Entry of appearance for Siegmund Y. Gutman; John E. Roberts; Amir A. Naini; David M. Hanna as counsel for Appellants Alvogen Pine Brook, LLC and Natco Pharma Limited. Service: 09/14/2021 by email. [799331] [21-2270] [Siegmund Gutman] [Entered: 09/14/2021 07:31 PM]
September 14, 2021 Filing 7 Docketing Statement for the Appellee Janssen Biotech, Inc.. Service: 09/14/2021 by clerk, email. [799299] [21-2270] [Irena Royzman] [Entered: 09/14/2021 04:36 PM]
September 14, 2021 Filing 6 Certificate of Interest for Appellee Janssen Biotech, Inc.. Service: 09/14/2021 by clerk, email. [799294] [21-2270] [Irena Royzman] [Entered: 09/14/2021 04:33 PM]
September 14, 2021 Filing 5 Entry of appearance for Irena Royzman; Hannah Lee; Christine Willgoos as counsel for Appellee Janssen Biotech, Inc.. Service: 09/14/2021 by clerk, email. [799292] [21-2270] This document is non-compliant. See Doc No.[ # 12 ] [Irena Royzman] [Entered: 09/14/2021 04:31 PM]
September 14, 2021 Filing 4 Docketing Statement for the Appellee Pharmacyclics LLC. Service: 09/14/2021 by email. [799187] [21-2270] [Christopher Sipes] [Entered: 09/14/2021 02:48 PM]
September 14, 2021 Filing 3 Certificate of Interest for Appellee Pharmacyclics LLC. Service: 09/14/2021 by email. [799180] [21-2270] [Christopher Sipes] [Entered: 09/14/2021 02:41 PM]
September 14, 2021 Filing 2 Entry of appearance for Christopher N. Sipes; Erica N. Andersen; Brianne Bharkhda; Laura E. Dolbow as counsel for Appellee Pharmacyclics LLC. Service: 09/14/2021 by email. [799178] [21-2270] [Christopher Sipes] [Entered: 09/14/2021 02:38 PM]
August 31, 2021 Filing 1 Appeal docketed. Received: 08/30/2021. [796376] Entry of Appearance is due on 09/14/2021. Certificate of Interest is due on 09/14/2021. Docketing Statement is due on 09/14/2021. Appellants' brief is due on 11/01/2021. [JCW] [Entered: 08/31/2021 03:36 PM]

Access additional case information on PACER

Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Search for this case: Pharmacyclics LLC v. Alvogen, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff / appellee: PHARMACYCLICS LLC
Represented By: Jack B. Blumenfeld
Represented By: Christopher Neil Sipes Esq.
Represented By: Erica Nicole Andersen Esq.
Represented By: Brianne Bharkhda
Represented By: Laura Dolbow
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff / appellee: JANSSEN BIOTECH, INC.
Represented By: Jack B. Blumenfeld
Represented By: Hannah Yunkyung Lee
Represented By: Irena Royzman
Represented By: Christine Willgoos
Represented By: Daniel David Williams
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: ALVOGEN PINE BROOK, LLC
Represented By: James L. Higgins
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: NATCO PHARMA LIMITED
Represented By: James L. Higgins
Represented By: Siegmund Y. Gutman
Represented By: David M. Hanna
Represented By: Amir A. Naini
Represented By: John E. Roberts
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: ALVOGEN, INC.
Represented By: Siegmund Y. Gutman
Represented By: David M. Hanna
Represented By: Amir A. Naini
Represented By: John E. Roberts
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?